Related Experiment Video

Updated: May 5, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.5K

Application of dsRNA in cancer immunotherapy: current status and future trends

Bo Jin, Liu-Fang Cheng, Kai Wu

  • 1Department of Gastroenterology, The 309th Hospital of the Chinese People's Liberation Army, A17 Heishanhu Rd., Beijing 100091, China. vze2jy85@yahoo.com.

Anti-Cancer Agents in Medicinal Chemistry
|November 19, 2013
PubMed

Insights

Double-stranded RNA (dsRNA) analogs activate pattern recognition receptors (PRRs) to stimulate anti-cancer immune responses and programmed cell death. This review explores dsRNA signaling pathways and their clinical use in cancer therapy.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Cancer cells establish an immunosuppressive microenvironment, hindering tumor rejection.
  • Pattern recognition receptors (PRRs) are crucial for initiating innate and adaptive immune responses against tumors.

Purpose of the Study:

  • To review the signal pathways activated by double-stranded RNA (dsRNA).
  • To examine the clinical applications of dsRNA analogs in cancer treatment.

Main Methods:

  • Review of scientific literature on dsRNA, PRRs, and cancer immunology.
  • Analysis of signaling cascades triggered by dsRNA analogs (e.g., TLR3, RIG-I, MDA5, NLRP3).

Main Results:

  • dsRNA analogs activate multiple PRRs, including TLR3, RIG-I, MDA5, and NLRP3.
  • Activation leads to robust immune responses and programmed cell death in cancer cells.

Conclusions:

  • dsRNA analogs hold significant potential for cancer immunotherapy.
  • Understanding dsRNA-mediated signaling pathways is key to developing effective cancer treatments.

More Related Videos

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.9K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K